Verrica Pharmaceuticals (VRCA) PT Lowered to $3 at Jefferies
Tweet Send to a Friend
Jefferies analyst Glen Santangelo lowered the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $3.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
